论文部分内容阅读
目的探讨眼底激光联合曲安奈德治疗糖尿病性视网膜病变(diabetic retinopathy,DR)的临床效果。方法单眼DR患者102例,分为两组。观察组,选取2012年10月至2013年10月单眼DR患者53例,采用眼底激光手术联合玻璃体腔注射曲安奈德治疗,激光手术治疗前1周给予曲安奈德注射;对照组,选取2011年9月至2012年9月单眼DR患者49例,单纯应用眼底激光治疗,光斑直径200~300μm,曝光时间0.1~0.2 s,初始治疗功率为100 m W。术后1周,1、3和6个月进行随访,观察两组患者治疗后视力水平、眼底改善及并发症等情况。结果观察组53例,视力提高率为67.9%,视力下降率为13.2%,疗效好于对照组,两组比较差异具有显著意义(P<0.05)。治疗后观察组患者的眼底出血、渗出、视网膜水肿与黄斑区视网膜厚度均明显优于对照组,具有统计学意义(P<0.05)。结论眼底激光联合曲安奈德联合治疗DR,可明显改善患者的视网膜相关症状,对其视力恢复具有良好作用。
Objective To investigate the clinical effects of fundus laser combined with triamcinolone acetonide in the treatment of diabetic retinopathy (DR). Methods 102 patients with monocular DR were divided into two groups. The observation group was selected from October 2012 to October 2013 53 patients with monocular DR, fundus laser combined with intravitreal injection of triamcinolone acetonide injection, triamcinolone acetonide injection before laser surgery 1 week; control group, select 2011 From September to September 2012, 49 patients with monocular DR were treated with fundus laser only. The spot diameter was 200-300μm, the exposure time was 0.1-0.2s, and the initial treatment power was 100 mW. One week, one, three and six months after operation were followed up. The visual acuity, fundus and complications of the two groups were observed after treatment. Results 53 cases of observation group, visual acuity improvement rate was 67.9%, vision loss rate was 13.2%, the effect is better than the control group, the difference between the two groups was significant (P <0.05). After treatment, the fundus hemorrhage, exudation, retinal edema and macular retinal thickness in observation group were significantly better than those in control group, with statistical significance (P <0.05). Conclusion Fundus laser combined with triamcinolone acetonide treatment of DR, can significantly improve the patient’s retinal related symptoms, its visual acuity has a good effect.